CTXR CIK: 1506251

Citius Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.3
FY22:
−28.4
FY23:
−29.1
FY24:
−28.2
FY25:
−26.6
Change from FY21 to FY25
millions USD
FY21:
−40.0
FY22:
–
FY23:
–
FY24:
−5.00
FY25:
−5.75
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
–
FY23:
13.8
FY24:
9.97
FY25:
33.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.3
FY22:
–
FY23:
–
FY24:
–
FY25:
−26.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data